PR95645

SEOUL, South Korea, April 26, 2022 /PRNewswire=KYODO JBN/ --

The Korea Society of Ginseng disclosed the results of a study titled The Effect

of Red Ginseng on Improving Fatigue, Lethargy and Stress Resistance at The

Korea Society of Ginseng Spring Conference in 2022 held at Sejong University on

the 21st. In particular, the timeliness of the results of this study are

especially meaningful since an increasing number of people have complained of

lingering fatigue and lethargy following recovery from coronavirus infection.

- Red ginseng effectively reduces fatigue and stress.

Kim Kyung-chul, a family medicine specialist, analyzed 76 male and female

subjects ranging in age from 20 to 70 who have experienced fatigue and stress

at least once a week. He compared the subjects by dividing them into the red

ginseng group (50 people) and the placebo group (26 people). As a result, he

confirmed that the red ginseng group felt less fatigue and lethargy while

boosting their resistance to stress. In particular, the effect was more notable

in those suffering chronic fatigue from parasympathetic dominance.

-  Consumption of red ginseng improved fatigue symptoms and antioxidant

capacity.

Professor Jeong Tae-ha of the Department of Family Medicine at Wonju Severance

Christian Hospital and Professor Lee Yong-je of the Department of Family

Medicine at Gangnam Severance Hospital conducted a randomized, double-blind

placebo-controlled study for eight weeks with a total of 63 menopausal women.

As a result, it was confirmed through this randomized placebo-controlled

clinical trial that the number of mitochondrial DNA copies and antioxidant

capacity increased, and fatigue symptoms improved in the red ginseng group as

biological aging indicators.

Many previous studies have also confirmed this fatigue improvement effect of

red ginseng.

- Taking red ginseng improves fatigue, mood, walking ability, and enjoyment of

life in cancer patients.

Researchers from 15 institutions in Korea, including Professor Kim Yeol-hong,

Department of Oncology and Hematology, Korea University Anam Hospital, randomly

assigned 438 colorectal cancer patients receiving mFOLFOX-6 therapy to the red

ginseng group (219 people) and placebo group (219 people). The red ginseng

group took 1000mg of red ginseng twice a day during the 16 weeks of

chemotherapy. As a result, the fatigue level of the red ginseng group was

significantly improved compared to the placebo group.

*References

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777686/

https://journals.lww.com/md-journal/Fulltext/2021/10290/Ginseng_adjuvant_therapy_on_COVID_19__A_protocol.12.aspx

https://www.ejcancer.com/article/S0959-8049(20)30072-1/fulltext

Source The Korean Society of Ginseng

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=419849

   Caption: Photo by The Korea Society of Ginseng